Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05739656 · ClinicalTrials.gov registry record
Evaluation of Visual Acuity of the Envista One-piece Acrylic Toric IOL MX60ET
A clinical trial, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- 100
- Enrollment target
NCT05739656: Completed study, sponsored by Bausch & Lomb Incorporated.
NCT05739656 is a clinical trial that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05739656 has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate rotational stability and functional improvements in visual acuity of the enVista monofocal Toric IOL (MX60ET) following cataract surgery.
Primary Outcome
The proportion of subjects with absolute lens axis rotation from surgical placement of less than or equal to 20 degrees. Tertiary/Supportive/Other effectiveness outcomes will include the following. * Uncorrected and distance-corrected visual acuities at 66 cm and at 4 m * Manifest refraction * Subjective questionnaire
Interventions
- PROCEDURE CATARACT SURGERY
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2020-08-01 |
| Est. Completion | 2022-07-06 |
What the finished NCT05739656 record still lists
NCT05739656 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which CATARACT SURGERY is the first listed.
NCT05739656 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05739656 about?
NCT05739656 is a clinical study titled "Evaluation of Visual Acuity of the Envista One-piece Acrylic Toric IOL MX60ET". The primary objective of this study is to evaluate rotational stability and functional improvements in visual acuity of the enVista monofocal Toric IOL (MX60ET) following cataract surgery.
What is the current status of trial NCT05739656?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2020-08-01. Estimated completion is 2022-07-06.
What interventions are being tested in trial NCT05739656?
The interventions under investigation include: CATARACT SURGERY (PROCEDURE).
Who is sponsoring clinical trial NCT05739656?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI